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Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder with 1–3%
prevalence. OCD is characterized by recurrent thoughts (obsessions) and repetitive
behaviors (compulsions). The pathophysiology of OCD remains unclear, stressing the
importance of pre-clinical studies. The aim of this article is to critically review a proposed
animal model of OCD that is characterized by the induction of compulsive checking
and behavioral sensitization to the D2/D3 dopamine agonist quinpirole. Changes in this
model have been reported at the level of brain structures, neurotransmitter systems
and other neurophysiological aspects. In this review, we consider these alterations in
relation to the clinical manifestations in OCD, with the aim to discuss and evaluate
axes of validity of this model. Our analysis shows that some axes of validity of
quinpirole sensitization model (QSM) are strongly supported by clinical findings, such as
behavioral phenomenology or roles of brain structures. Evidence on predictive validity
is contradictory and ambiguous. It is concluded that this model is useful in the context
of searching for the underlying pathophysiological basis of the disorder because of the
relatively strong biological similarities with OCD.
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INTRODUCTION
Obsessive-compulsive disorder (OCD) is a chronic, heritable and debilitating neuropsychiatric
disorder with a lifetime prevalence of about 1–3% (Stein, 2002). The etiology of OCD remains
unclear. It has been shown that approximately 47% of the variance in OCD is explained by genetic
factors and the remaining variance depends on environmental factors (van Grootheest et al., 2005).
Commonly discussed potential causes include the pathophysiological effects of infections and stress
and traumas in childhood. These influences have significant effects on the central nervous system,
specific anatomical circuits and neurotransmitter systems.
Scientists widely use animal models to understand the disease mechanisms and search
for new therapies. An animal model can barely mimic the entire disease in all its aspects.
Abbreviations: ACC, Anterior cingulate cortex; CMI, Clomipramine; DBS, Deep brain stimulation; fMRI, Functional
magnetic resonance imaging; NAc, Nucleus accumbens; OCD, Obsessive-compulsive disorder; OFC, Orbitofrontal
cortex; QSM, Quinpirole sensitization model; SRIs, Serotonin reuptake inhibitors; SSRIs, Selective serotonin re-uptake
inhibitors; STN, Subthalamic nucleus; TCA, Tricyclic antidepressants.
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The animal models are considered tools for evaluating
mechanisms which may play the role in particular disease
rather than ‘‘mini-versions’’ of the disease in animals.
Evaluation of aspects linking animal model and disease is
based on a concept of models in general (e.g., Rosenblueth
and Wiener, 1945). This concept was adapted to modeling
of neuropsychiatric diseases in animals by Willner (1986).
Sets of criteria in which an animal model represents
components of the disease are called axes of validity. These
can be classified into three categories: face, construct and
predictive axes of validity (Willner, 1986). Face validity
corresponds to homologies seen in behaviors as the main
phenomenological outcomes observable both in model species
and humans. Construct validity corresponds to involvement
of the same neurophysiological mechanisms and changes in
the brain circuits (Albelda and Joel, 2012). Predictive validity
corresponds to the predictability of treatment outcomes, or
in a more general view, to the power of a given model to
explain the clinical findings. This division is still useful in
describing animal models, although some refinements in these
criteria have been presented as well (Belzung and Lemoine,
2011).
Animal models of OCD can be classified into three main
types: genetic, behavioral and pharmacological models. They
have been reviewed in several excellent works (e.g., Eilam et al.,
2006; Albelda and Joel, 2012; Alonso et al., 2015; Szechtman
et al., 2016). This review aims at discussing and evaluating
axes of validity of a model based on behavioral sensitization of
rats to quinpirole. This model is characterized by compulsive
checking, a form of rituals present in one of the symptom
dimensions in OCD. The essentially pharmacological nature
of this model allows the study of brain substrates underlying
these behavioral changes and to directly compare them with a
clinical situation. There is relatively extensive neurobiological
evidence on this model. This fact allowed us to evaluate in
detail it validity, focusing on the aforementioned three main
axes.
QUINPIROLE SENSITIZATION RAT MODEL
(QSM)
An established pharmacological animal model of obsessive-
compulsive disorder is based on chronic administration of
quinpirole, an agonist of dopaminergic D2 and D3 receptors.
This treatment induces behavioral sensitization to quinpirole
and compulsive-checking behavior that is phenomenologically
similar to human compulsive checking rituals. Its potential
to model compulsive-checking symptoms of OCD was
described in detail by Szechtman et al. (1998), but quinpirole
effects on animal behavior had been studied already in
older works with ethological and behavioral-pharmacology
approaches (e.g., Eilam and Golani, 1989). These studies
showed route-, but not-movement-related stereotypical
patterns. Origins of the ethological criteria for defining
these patterns in the quinpirole sensitization model (QSM)
come from earlier studies by Eilam and Golani (1988,
1989).
FACE VALIDITY OF THE QSM
OCD Phenomenology
OCD is characterized by recurrent thoughts (obsessions)
and repetitive behaviors (compulsions). Compulsions are
often reported by patients to ‘‘neutralize’’ obsessions and
reduce obsession-related anxiety (Stein, 2002). Obsessive and
compulsive symptoms can be defined in several principal
domains. It was proposed that they could be mediated by a
deficit in behavioral flexibility, such as the ability to shift focus
of attention. Indeed such deficits were demonstrated in specific
task-switching and reversal learning paradigms (Chamberlain
et al., 2005, 2006). Additionally disruptions of recognizing
conflicting information (Ciesielski et al., 2011) can play a
role. OCD has substantial negative effects on the patient’s
quality of life, and carries a considerable socio-economic
burden at the population level (Olesenn et al., 2012). OCD
is a heterogeneous disorder and there are many different
ways by which OCD can manifest in patients. There is
also no specific age of onset or single etiology. Additionally,
treatment responses and comorbidities in patients vary to a large
extent.
QSM Phenomenology
Quinpirole-sensitized animals exhibit excessive checking, and
perseverative as well as altered reward-related behaviors. The
QSM was discovered serendipitously during experiments with
animal models of psychosis (Szechtman et al., 1994). It was
its face validity that made researchers to consider it as an
animal model of OCD. The uniqueness of this animal model
lies in modeling OCD symptomology related to symmetry
obsessions—compulsive checking (Mataix-Cols, 2006). Since it
is challenging to directly compare human and animal behavior,
a set of ethological criteria of compulsive behavior were devised
(Szechtman et al., 1998). These criteria can describe both animal
and human behavior in ethological terms: first, there are one or
two particular (key) places/objects to which the subject returns
more excessively than to other places/objects in the subject’s
living space. Second, these particular places/objects are visited
significantly more often than others. Third, a limited number of
places are visited in between returns to the key places/objects.
Fourth, a characteristic set of acts is performed at the particular
places/objects. Finally, this set of acts is dependent on particular
places/objects and change when the environmental properties of
the places/objects are altered (Szechtman et al., 1998).
All these five criteria were shown to apply both to OCD
patients and to the QSM (Eilam et al., 2012). This important
article conceptualized these ethological criteria as translational
tools for studying OCD patients. When a quinpirole-sensitized
animal is repeatedly placed in an open field with several (usually
four) objects placed at fixed locations, the rat generally directs
its activity towards one or two objects and a ‘‘home-base’’.
Home-base is a place to which the animal returns most often
(Szechtman et al., 1994, 1998, 2001). The animal thus visits
excessively a relatively small number of available places. This
is analogous to a patient who focuses on checking mostly the
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objects of his/her obsession during his compulsive rituals. If a
home cage is placed in the open-field arena in which the rat
conducts its checking behavior, it remains in the home cage for
a while before coming out and resuming its checking activities
again. Analogously, patients can usually withhold their checking
behavior, but eventually they resume checking after some time.
Excessive perseverative behavior in the QSM animals has been
shown in spontaneous alternation (SA) in a T-maze. SA is an
intriguing phenomenon observable in many biological systems
that has not been fully explained yet. During SA, intact animals
enter a different arm of the T-maze in the next trial then on
previous one. Quinpirole-sensitized animals alternate much less
than control animals (Einat and Szechtman, 1995). This means
that they show increased perseverative behavior similar to OCD
patients (Yadin et al., 1991).
Quinpirole-sensitized animals also display abnormal
reward-related behavior. They choose to work for a reward
instead of choosing a freely available source (Jensen, 1963; Koffer
et al., 1971). This phenomenon is called contrafreeloading. In
excess, contrafreeloading is considered to be a manifestation
of compulsive behavior (Amato et al., 2007; De Carolis et al.,
2011). As an example of this paradigm, water-deprived animals
are first trained to press a lever to receive a small amount of
water. This part is called the operant conditioning phase. It
is followed by a choice phase. Here animals can obtain water
either by pressing a lever or directly from a freely available
water container. Quinpirole-sensitized animals chose to obtain
water significantly more by means of lever pressing than do
saline treated animals. Also, quinpirole sensitized animals did
not drink all the water they obtained. Actually they drank
less water than saline treated animals (hypodipsia; Cioli et al.,
2000; De Carolis et al., 2011; Schepisi et al., 2013). This shows
that increased lever pressing was not driven by increased
thirst.
Cognitive impairments, mainly at the level of behavioral
flexibility are also considered intermediate phenotypes in OCD.
Therefore, they could support the face validity of the QSM.
Although sparse, there have been several studies observing
cognitive impairments in the QSM. They were similar to those
in OCD patients. As mentioned above, SA was found deficient in
the QSM (Einat and Szechtman, 1995). Moreover, a significant
deficit in the QSM was found in reversal learning (Boulougouris
et al., 2009; Hatalova et al., 2014). Beside implications for OCD,
these findings also suggest the involvement of D2/D3 receptors
in these types of flexible behavior.
CONSTRUCT VALIDITY OF THE QSM
Neurobiological Changes in OCD
Despite the clear heterogeneity of OCD, there is a consensus
in the involvement of the cortico-striatal circuits in OCD
pathophysiology. Nonetheless, there is not yet a clear and
complete answer as to which structures are altered in these
circuits. There are structural (or volumetric), as well as functional
changes. Structures that are associated with OCD include the
orbitofrontal cortex (OFC), anterior cingulate cortex (ACC),
prefrontal and parietal cortices, the caudate nucleus (Menzies
et al., 2008), and nucleus accumbens (Figee et al., 2013b). These
findings are consistent with most circuit models of OCD (Saxena
et al., 1998; Menzies et al., 2008; Rotge et al., 2008) which
propose that the pathophysiology of OCD reflects a dysfunction
in the neuroanatomical network of cortical-basal ganglia loops
described by Alexander et al. (1986).
Neurobiological Changes in the QSM
The construct validity of the QSM is supported by the
involvement of D2 dopamine receptors and the involvement of
the striatum and the OFC. Following quinpirole sensitization,
changes in striatal structures have been observed in the QSM.
An increase of D2 receptor binding (Culver et al., 2008) and
decrease of glucose utilization was observed in the NAc after
sensitization with quinpirole. Importantly these changes were
not seen after acute treatment with quinpirole (Carpenter et al.,
2003). Additionally, de Haas et al. (2011) have shown alterations
in dopamine efflux in the nucleus accumbens in the QSM
compared to intact animals.
Another brain region of interest in OCD is the OFC.
Interestingly, a lesion of the OFC affects the focus of
goal-directed activity in compulsive checking (Dvorkin
et al., 2010). OFC hyperactivity is considered one of the
most prominent intermediate phenotypes of OCD (Ursu
and Carter, 2010). Additional interesting results have come
from another article by Dvorkin et al. (2008), which showed
that hypophysectomy resulting in complex neuro-humoral
dysbalances attenuated the locomotor sensitization of quinpirole.
Notably it had no effect upon compulsive checking in sensitized
animals.
Additionally, it has been shown (Schmidt et al., 2013) that
quinpirole sensitization also increased the rewarding effects
of d-amphetamine. This is important because a link between
changes in reward systems, impulsivity and psychiatric disorders
including OCD has been convincingly documented (Eslami-
Shahrbabaki et al., 2015; Grassi et al., 2015). An important
implication of the quinpirole sensitization in relation to
neurobiology is a proposal that OCD as a clinical condition
can represent a disorder of a ‘‘security motivation’’ system
(Szechtman and Woody, 2004). This is a special motivational
system of the brain responsible for anticipating potential, but
uncertain, future life-threatening situations.
Based on the above mentioned results, we predict that in
the QSM, other specific neurobiological changes will be shown.
These may include increased connectivity between selected parts
of cortico-striatal loops and altered neurotransmission, which
may result in deeper attractor basins, defined by a computational
stochastic framework of dynamic network theory (Rolls, 2012).
PREDICTIVE VALIDITY OF THE QSM
Serotonin-Reuptake Inhibitors and
Non-Specific Drugs
A widely used pharmacotherapeutic approach for OCD today is
the administration of serotonin-reuptake inhibitors (SRIs)
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and some relatively non-specific drugs such as tricyclic
antidepressants (TCA; e.g., clomipramine; CMI). CMI
(Cartwright and Hollander, 1998) is a TCA that acts as a
serotonin reuptake inhibitor and antagonist/inverse agonist of
histamine H1 receptors, muscarinic acetylcholine receptors,
alpha1 adrenergic receptors and dopamine D2 receptors.
Effectiveness of SRIs and TCA in OCD triggered studies
on the involvement of the serotonergic system in OCD
pathophysiology. CMI treatment is effective in only approx.
50% of patients (Leonard et al., 1989). In the QSM, CMI
co-administered with quinpirole attenuated compulsive checking
(Szechtman et al., 1998). CMI is also effective in reversing
another type of OCD-related behavior in quinpirole-sensitized
rats—the aforementioned contrafreeloading (Amato et al., 2008;
De Carolis et al., 2011). However, the original work on the
attenuating effect of CMI demonstrated that this action was
transient (Szechtman et al., 1998). Moreover, our new findings
show a negative effect of CMI in the QSM on acquisition of
spatial learning in an active place avoidance task on a rotating
arena (Carousel; Hatalova et al., 2016). This study suggests
that adverse effect of CMI on learning the spatial relationships
in the QSM might represent a possible interpretation of
CMI’s effect on object checking—if animals in the QSM
treated with CMI could not learn the spatial associations of
places or objects, they could not show the path stereotypies
in relation to these objects. Together, these findings provide
somewhat contradictory evidence and fail to unequivocally
support predictive validity of the QSM of OCD in relation
to CMI.
Rather than the TCA clomipramine, first-line treatments
for OCD are now selective serotonin reuptake inhibitors
(SSRIs), often combined with cognitive-behavioral therapy
(CBT). The introduction of SSRIs represented great progress
in the treatment of OCD, since they produce fewer side-effects
than CMI. The most commonly used SSRIs are fluoxetine,
fluvoxamine and paroxetine. Unfortunately, there are
limits to the therapeutic efficiency of serotonin reuptake
inhibitors. It has been found that approximately 40% of
OCD patients do not show an improvement in symptoms
following SSRI monotherapy (Skoog and Skoog, 1999;
Pallanti et al., 2002). If this first attempt fails then different
pharmacological procedures can be tried. Possibilities include
changes in dosage (Ninan et al., 2006), route/method of drug
administration (Fallon et al., 1998), switching to another
serotonin reuptake inhibitor (Fineberg et al., 2015) and addition
of neuroleptic drugs (McDougle et al., 1994; Hollander et al.,
2003).
Surprisingly, the QSM has never been validated with SSRIs
treatment. This stands a bit in contrast with some other models,
including behavioral models such as compulsive lever-pressing
or genetics models. Only one study tested fluoxetine in the
QSM. It has shown that chronic administration of fluoxetine
had potentiating effect on locomotor hyperactivity induced by
quinpirole, but did not have any effect on stereotyped behavior
in the QSM (Collu et al., 1997). Repetitive behavior induced by
repeated optogenetic stimulation of cortico-striatal circuits was,
however, sensitive to fluoxetine (Ahmari et al., 2013).
Antipsychotic Drugs
In some patients, co-administration of SSRIs or TCA with
classical or atypical neuroleptic drugs improves the efficiency
of treatment. Haloperidol and risperidone are the most
often used antipsychotics for augmenting SSRI treatment
in OCD (McDougle et al., 1994; Hollander et al., 2003).
Our data obtained in the QSM suggest a beneficial effect
of risperidone added to CMI on performance in an active
place avoidance task in the Carousel (Hatalova et al., 2016).
However, administration of other antipsychotic drugs such
as haloperidol or aripiprazole (dopamine stabilizer) did
not improve other OCD-like symptoms (contrafreeloading
and hypodipsia) in the QSM (De Carolis et al., 2011).
It should be noted that not enough data is available on
the effects of antipsychotic drugs in the QSM as there
are issues of dosing and schedule that had not been
addressed yet.
Other Pharmacological Substances and
Future Challenges
Studies suggest new approaches for cases with inadequate
treatment response to SSRI and/or cognitive behavioral
therapy. These include augmentation not only with the
above- mentioned antipsychotics, but also use of novel drugs
acting on glutamate or acetylcholine systems. Nicotine, the
agonist of the nicotinic acetylcholine receptor, has been
shown to reduce compulsions in OCD patients (Salín-
Pascual and Basañez-Villa, 2003; Lundberg et al., 2004) as
well as checking in quinpirole-sensitized animals (Tizabi
et al., 2002), supporting the predictive validity of this
model.
Deep Brain Stimulation and Neurosurgery
In very serious treatment-resistant OCD cases, deep brain
stimulation (DBS) or lesions of brain structures within the
cortico-striatal loops may be indicated. DBS is based on
high-frequency stimulation of a subcortical brain region, which
has an inhibitory effect on nerve tissue and mimics the effect
of permanent lesion to some extent (Bourne et al., 2012).
The main target structures in OCD patients are the anterior
limb of the internal capsule, nucleus accumbens (NAc), ventral
capsule/ventral striatum, and subthalamic nucleus (STN; Kohl
et al., 2014). Of these, the DBS of the NAc and STN has
been tested in the QSM. DBS of the NAc shell and core
(Mundt et al., 2009) as well as the STN (Winter et al.,
2008) decreased checking behavior in the QSM. High-frequency
stimulation of globus pallidus and entopeduncular nucleus
also reduced checking in the QSM (Djodari-Irani et al.,
2011).
The most invasive and irreversible method for treating highly
refractory OCD patients is neurosurgical treatment. Significant
improvements in patient conditions have been described in
anterior cingulotomy, anterior capsulotomy and others (Mindus
and Jenike, 1992). The procedure mechanism lies in the
disruption of reciprocal connections between cortical areas and
subcortical structures. Surprisingly, a reduction in symptom
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severity is observed with a delay of 3–6 months (Doshi, 2009).
Studies with the QSM have revealed that a lesion to the NAc
increased checking behavior in saline-treated rats while it did
not abolish compulsive checking. Instead, it increased vigor
of motor performance (Dvorkin et al., 2010). It is possible
that the NAc may be a site for the negative feedback control
of checking. The effects of lesions or inactivations of other
brain structures involved in OCD circuits in QSM remain yet
to be fully understood. The ACC is of particular interest in
this context. Functional hyperactivity and decreased volume in
this area has been shown repeatedly by converging evidence
from different methods (Koprˇivová et al., 2011, 2013a,b) yet no
study has been aimed to assess the effects of cingulotomy in
the QSM.
Together, this suggests that quinpirole exerts its effect on
checking behavior by inhibiting the NAc. Notably, a recent
study showed that lesion of the NAc did not prevent the
development of compulsive checking in the QSM. It only reduced
the speed in which checking developed (Ballester González
et al., 2015). Interestingly, a recent human DBS study in OCD
patients showed that NAc-DBS reduced low-frequency EEG
oscillations recorded over the frontal cortex during symptom
provocation as well as resting-state functional connectivity
(fMRI) between NAc and the prefrontal cortex (Figee et al.,
2013a). Our previous as well as other studies reported medial
frontal low frequency EEG excess in OCD patients (e.g.,
Koprˇivová et al., 2011, 2013a,b). These findings support
the predictive validity of the QSM because similar to DBS,
quinpirole sensitization probably inhibits NAc. It would be
interesting to test if EEG changes in terms of increased
low-frequency bands in the frontal cortex are seen in the
QSM. If so, it would be interesting to see how these changes
in scalp-recorded EEG relate to intracranial EEG signals and
to other functional and structural brain changes. Finally, it
would be interesting to test if these potential EEG changes
may predict responses to various kinds of treatment. Such
electrophysiological studies on the QSM would be particularly
useful and highly clinically relevant as scalp-recorded EEG
is a cheap, non-invasive and widely available diagnostic
method.
CONCLUSION
OCD represents a significant challenge for neuropsychiatrists,
psychologists, neuroscientists and biomedical researchers in
general. For detailed explanations of the brain pathophysiology
of this disorder, the QSM could provide valuable insights.
The present review discusses the QSM and shows that it has
substantial face and construct validity. Evidence on the predictive
validity in relation to pharmacotherapy is more contradictory
and ambiguous, despite effects of invasive treatments such as
DBS and lesions being supportive. In our research, we propose
to use the model to continue the search for OCD-related
neurobiological and neurochemical changes.
AUTHOR CONTRIBUTIONS
AS, JK, DR and JH wrote major parts of the article. All other
authors critically reviewed and edited the article. The review was
written based on the expertise of the authors, who have sourced
the article on PubMed and Google Scholar.
FUNDING
This study was supported by research grant AZV 15-34524A
provided by the Ministry of Health, Czech Republic. All rights
reserved. Institutional support for Institute of Physiology was
provided by RVO: 67985823. Institutional support for NIMH
was provided by the project National Institute of Mental Health
(NIMH-CZ) grant number ED2.1.00/03.0078 (and the European
Regional Development Fund and by the project ‘‘Sustainability
for the National Institute of Mental Health’’, under grant number
LO1611, with financial support from the Ministry of Education,
Youth and Sports of the Czech Republic under the NPU I
program.
ACKNOWLEDGMENTS
We thank Vladimira Markova, Barbara Stuchlikova and
Veronika Lobellova for their helpful assistance and David
Hardekopf for language proofreading.
REFERENCES
Ahmari, S. E., Spellman, T., Douglass, N. L., Kheirbek, M. A., Simpson, H. B.,
Deisseroth, K., et al. (2013). Repeated cortico-striatal stimulation generates
persistent OCD-like behavior. Science 340, 1234–1239. doi: 10.1126/science.
1234733
Albelda, N., and Joel, D. (2012). Current animal models of obsessive compulsive
disorder: an update. Neuroscience 211, 83–106. doi: 10.1016/j.neuroscience.
2011.08.070
Alexander, G. E., and Crutcher, M. (1990). Functional architecture of basal ganglia
circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266–271.
doi: 10.1016/0166-2236(90)90107-l
Alexander, G. E., DeLong, M. R., and Strick, P. L. (1986). Parallel organization
of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev.
Neurosci. 9, 357–381. doi: 10.1146/annurev.neuro.9.1.357
Alonso, P., López-Solà, C., Real, E., Segalàs, C., and Menchón, J. M.
(2015). Animal models of obsessive-compulsive disorder: utility and
limitations. Neuropsychiatr. Dis. Treat. 11, 1939–1955. doi: 10.2147/NDT.
s62785
Amato, D., Milella, M. S., Badiani, A., and Nencini, P. (2007). Compulsive-like
effects of quinpirole on drinking behavior in rats are inhibited by substituting
ethanol for water. Behav. Brain Res. 177, 340–346. doi: 10.1016/j.bbr.2006.11.
016
Amato, D., Stasi, M. A., Borsini, F., and Nencini, P. (2008). Haloperidol
both prevents and reverses quinpirole-induced nonregulatory water intake, a
putative animal model of psychogenic polydipsia. Psychopharmacology (Berl)
200, 157–165. doi: 10.1007/s00213-008-1229-1
Ballester González, J., Dvorkin-Gheva, A., Silva, C., Foster, J., and Szechtman, H.
(2015). Nucleus accumbens core and pathogenesis of compulsive
checking. Behav. Pharmacol. 26, 200–216. doi: 10.1097/FBP.00000000000
00112
Belzung, C., and Lemoine, M. (2011). Criteria of validity for animal models of
psychiatric disorders: focus on anxiety disorders and depression. Biol. Mood
Anxiety Disord. 1, 9–23. doi: 10.1186/2045-5380-1-9
Frontiers in Behavioral Neuroscience | www.frontiersin.org 5 October 2016 | Volume 10 | Article 209
Stuchlik et al. Quinpirole Model of OCD
Boulougouris, V., Chamberlain, S. R., and Robbins, T. W. (2009). Cross-species
models of OCD spectrum disorders. Psych. Res. 170, 15–21. doi: 10.1016/j.
psychres.2008.07.016
Bourne, S. K., Eckhardt, C. A., Sheth, S. A., and Eskandar, E. N. (2012).
Mechanisms of deep brain stimulation for obsessive compulsive disorder:
effects upon cells and circuits. Front. Integr. Neurosci. 6:29. doi: 10.3389/fnint.
2012.00029
Carpenter, T. L., Pazdernik, T. L., and Levant, B. (2003). Differences in
quinpirole-induced local cerebral glucose utilization between naive and
sensitized rats. Brain Res. 964, 295–301. doi: 10.1016/s0006-8993(02)04115-x
Cartwright, C., and Hollander, E. (1998). SSRI is in the treatment of
obsessive-compulsive disorder. Depress. Anxiety 8, 105–113. doi: 10.
1002/(SICI)1520-6394(1998)8:1+<105::AID-DA16 >3.0.CO;2-T
Chamberlain, S. R., Blackwell, D., Fineberg, N., Robbins, T. W., and Sahakian, B. J.
(2005). The neuropsychology of obsessive compulsive disorder: the importance
of failures in cognitive and behavioural inhibition as candidate endophenotypic
markers. Neurosci. Biobehav. Rev. 29, 399–419. doi: 10.1016/j.neubiorev.2004.
11.006
Chamberlain, S. R., Fineberg, N. A., Blackwell, A. D., Robbins, T. W., and
Sahakian, B. J. (2006). Motor inhibition and cognitive flexibility in obsessive-
compulsive disorder and trichotillomania. Am. J. Psychiatry 163, 1282–1284.
doi: 10.1176/appi.ajp.163.7.1282
Ciesielski, K. T., Rowland, L. M., Harris, R. J., Kerwin, A. A., Reeve, A., and
Knight, J. E. (2011). Increased anterior brain activation to correct responses on
high-conflict Stroop task in obsessive-compulsive disorder. Clin. Neurophysiol.
122, 107–113. doi: 10.1016/j.clinph.2010.05.027
Cioli, I., Caricati, A., and Nencini, P. (2000). Quinpirole-and
amphetamine-induced hyperdipsia: influence of fluid palatability and
behavioral cost. Behav. Brain Res. 109, 9–18. doi: 10.1016/s0166-
4328(99)00155-2
Collu, M., Poggiu, A. S., Devoto, P., and Serra, G. (1997). Behavioural sensitization
of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated
rats. Eur. J. Pharmacol. 322, 123–127. doi: 10.1016/s0014-2999(97)
00006-x
Culver, K. E., Szechtman, H., and Levant, B. (2008). Altered dopamine D2-like
receptor binding in rats with behavioral sensitization to quinpirole: effects of
pre-treatment with Ro 41–1049. Eur. J. Pharmacol. 592, 67–72. doi: 10.1016/j.
ejphar.2008.06.101
De Carolis, L., Schepisi, C., Milella, M. S., and Nencini, P. (2011). Clomipramine,
but not haloperidol or aripiprazole, inhibits quinpirole-induced water
contrafreeloading, a putative animal model of compulsive behavior.
Psychopharmacology (Berl) 218, 749–759. doi: 10.1007/s00213-011
-2372-7
de Haas, R., Nijdam, A., Westra, T. A., Kas, M. J., and Westenberg, H. G. (2011).
Behavioral pattern analysis and dopamine release in quinpirole-induced
repetitive behavior in rats. J. Psychopharmacol. 25, 1712–1719. doi: 10.
1177/0269881110389093
Djodari-Irani, A., Klein, J., Banzhaf, J., Joel, D., Heinz, A., Harnack, D.,
et al. (2011). Activity modulation of the globus pallidus and the nucleus
entopeduncularis affects compulsive checking in rats. Behav. Brain Res. 219,
149–158. doi: 10.1016/j.bbr.2010.12.036
Doshi, P. K. (2009). Surgical treatment of obsessive-compulsive disorders:
current status. Indian J. Psychiatry 51, 216–221. doi: 10.4103/0019-5545.
55095
Dvorkin, A., Culver, K. E., Waxman, D., Szechtman, H., and Kolb, B. (2008).
Effects of hypophysectomy on compulsive checking and cortical dendrites
in an animal model of obsessive-compulsive disorder. Behav. Pharmacol. 19,
271–283. doi: 10.1097/FBP.0b013e3283095223
Dvorkin, A., Silva, C., McMurran, T., Bisnaire, L., Foster, J., and Szechtman, H.
(2010). Features of compulsive checking behavior mediated by nucleus
accumbens and orbital frontal cortex. Eur. J. Neurosci. 32, 1552–1563. doi: 10.
1111/j.1460-9568.2010.07398.x
Eilam, D., and Golani, I. (1988). The ontogeny of exploratory behavior in the house
rat (Rattus rattus): the mobility gradient. Dev. Psychobiol. 21, 679–710. doi: 10.
1002/dev.420210707
Eilam, D., and Golani, I. (1989). Home base behavior of rats (Rattus norvegicus)
exploring a novel environment. Behav. Brain Res. 34, 199–211. doi: 10.
1016/s0166-4328(89)80102-0
Eilam, D., and Szechtman, H. (1989). Biphasic effect of D-2 agonist quinpirole
on locomotion and movements. Eur. J. Pharmacol. 161, 151–157. doi: 10.
1016/0014-2999(89)90837-6
Eilam, D., Zor, R., Fineberg, N., and Hermesh, H. (2012). Animal behavior as a
conceptual framework for the study of obsessive-compulsive disorder (OCD).
Behav. Brain Res. 231, 289–296. doi: 10.1016/j.bbr.2011.06.033
Eilam, D., Zor, R., Szechtman, H., and Hermesh, H. (2006). Rituals, stereotypy
and compulsive behavior in animals and humans. Neurosci. Biobehav. Rev. 30,
456–471. doi: 10.1016/j.neubiorev.2005.08.003
Einat, H., and Szechtman, H. (1995). Perseveration without hyperlocomotion
in a spontaneous alternation task in rats sensitized to the dopamine agonist
quinpirole. Physiol. Behav. 57, 55–59. doi: 10.1016/0031-9384(94)00209-n
Escobar, A. P., Cornejo, F. A., Olivares-Costa, M., González, M., Fuentealba, J. A.,
Gysling, K., et al. (2015). Reduced dopamine and glutamate neurotransmission
in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory
D2 autoreceptor function. J. Neurochem. 134, 1081–1090. doi: 10.1111/jnc.
13209
Eslami-Shahrbabaki, M., Fekrat, A., and Mazhari, S. A. (2015). Study of the
prevalence of psychiatric disorders in patients with methamphetamine-induced
psychosis. Addict. Health 7, 37–46.
Fallon, B., Liebowitz, M., Campeas, R., Schneier, F., Marshall, R., Davies, S.,
et al. (1998). Intravenous clomipramine for obsessive-compulsive disorder
refractory to oral clomipramine. Arch. Gen. Psychiatry 55, 918–924. doi: 10.
1001/archpsyc.55.10.918
Figee, M., Luigjes, J., Smolders, R., Valencia-Alfonso, C. E., van Wingen, G., de
Kwaasteniet, B., et al. (2013a). Deep brain stimulation restores frontostriatal
network activity in obsessive-compulsive disorder. Nat. Neurosci. 16, 386–387.
doi: 10.1038/nn.3344
Figee, M., Wielaard, I., Mazaheri, A., and Denys, D. (2013b). Neurosurgical targets
for compulsivity: what can we learn from acquired brain lesions? Neurosci.
Biobehav. Rev. 39, 328–339. doi: 10.1016/j.neubiorev.2013.01.005
Fineberg, N., Reghunandanan, S., Simpson, H. B., Phillips, K., Richter, M.,
Matthews, K., et al. (2015). Obsessive-compulsive disorder (OCD): practical
strategies for pharmacological and somatic treatment in adults. Psychiatry Res.
227, 114–1125. doi: 10.1016/j.psychres.2014.12.003
Grassi, G., Pallanti, S., Righi, L., Figee, M., Mantione, M., Denys, D., et al.
(2015). Think twice: impulsivity and decision making in obsessive-compulsive
disorder. J. Behav. Addict. 4, 263–272. doi: 10.1556/2006.4.2015.039
Hatalova, H., Radostova, D., Pistikova, A., Vales, K., and Stuchlik, A.
(2014). Spatial reversal learning in chronically sensitized rats and in
undrugged sensitized rats with dopamine D2-like receptor agonist
quinpirole. Front. Behav. Neurosci. 8:122. doi: 10.3389/fnbeh.2014.
00122
Hatalova, H., Radostova, D., Pistikova, A., Vales, K., and Stuchlik, A. (2016).
Detrimental effect of clomipramine on hippocampus-dependent learning in an
animal model of obsessive-compulsive disorder induced by sensitization with
d2/d3 agonist quinpirole. Behav. Brain Res. 317, 210–217. doi: 10.1016/j.bbr.
2016.09.042
Hollander, E., Baldini Rossi, N., Sood, E., and Pallanti, S. (2003). Risperidone
augmentation in treatment-resistant obsessive-compulsive disorder: a double-
blind, placebo-controlled study. Int. J. Neuropsychopharmacol. 6, 397–401.
doi: 10.1017/s1461145703003730
Jensen, G. D. (1963). Preference for bar pressing over ‘‘freeloading’’ as a
function of number of rewarded presses. J. Exp. Psychol. 65, 451–454. doi: 10.
1037/h0049174
Koffer, K., Coulson, G., and Hospital, W. P. (1971). Feline indolence: cats
prefer free to response-produced food. Psychon. Sci. 24, 41–42. doi: 10.
3758/bf03331767
Kohl, S., Schönherr, D. M., Luigjes, J., Denys, D., Mueller, U. J., Lenartz, D., et al.
(2014). Deep brain stimulation for treatment-refractory obsessive compulsive
disorder: a systematic review. BMCPsychiatry 14:214. doi: 10.1186/s12888-014-
0214-y
Koprˇivová, J., Congedo, M., Horácˇek, J., Prasko, J., Raszka, M., Brunovský, M.,
et al. (2011). EEG source analysis in obsessive-compulsive disorder. Clin.
Neurophysiol. 122, 1735–1743. doi: 10.1016/j.clinph.2011.01.051
Koprˇivová, J., Congedo, M., Raszka, M., Prasko, J., Brunovský, M., and Horácˇek, J.
(2013a). Prediction of treatment response and the effect of independent
component neurofeedback in obsessive-compulsive disorder: a randomized,
Frontiers in Behavioral Neuroscience | www.frontiersin.org 6 October 2016 | Volume 10 | Article 209
Stuchlik et al. Quinpirole Model of OCD
sham-controlled, double-blind study. Neuropsychobiology 67, 210–223. doi: 10.
1159/000347087
Koprˇivová, J., Horácˇek, J., Raszka, M., Brunovský, M., and Prasko, J.
(2013b). Standardized low-resolution electromagnetic tomography in
obsessive-compulsive disorder—a replication study. Neurosci. Lett. 548,
185–189. doi: 10.1016/j.neulet.2013.05.015
Leonard, H., Swedo, S., Rapoport, J., Koby, E., Lenane, M., Cheslow, D.,
et al. (1989). Treatment of obsessive-compulsive disorder with clomipramine
and desipramine in children and adolescents: a double-blind crossover
comparison. Arch. Gen. Psychiatry 46, 1088–1092. doi: 10.1001/archpsyc.1989.
01810120030006
Lundberg, S., Carlsson, A., Norfeldt, P., and Carlsson, M. L. (2004). Nicotine
treatment of obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol.
Psychiatry 28, 1195–1199. doi: 10.1016/j.pnpbp.2004.06.014
Mataix-Cols, D. (2006). Deconstructing obsessive-compulsive disorder: a
multidimensional perspective. Curr. Opin. Psychiatry 19, 84–89. doi: 10.
1097/01.yco.0000194809.98967.49
McDougle, C. J., Goodman, W. K., Leckman, J. F., Lee, N., Heninger, G., and
Price, L. (1994). Haloperidole addition in fluvoxamine-refractory obsessive-
compulsive disorder: a double-blind, placebo-controlled study in patients with
and without tics. Arch. Gen. Psychiatry 51, 302–308. doi: 10.1001/archpsyc.
1994.03950040046006
Menzies, L., Chamberlain, S. R., Laird, A. R., Thelen, S. M., Sahakian, B. J.,
and Bullmore, E. T. (2008). Integrating evidence from neuroimaging
and neuropsychological studies of obsessive-compulsive disorder: the
orbitofronto-striatal model revisited. Neurosci. Biobehav. Rev. 32, 525–549.
doi: 10.1016/j.neubiorev.2007.09.005
Milad, M. R., and Rauch, S. L. (2012). Obsessive-compulsive disorder: beyond
segregated cortico-striatal pathways. Trends Cogn. Sci. 16, 43–51. doi: 10.1016/j.
tics.2011.11.003
Mindus, S., and Jenike, M. (1992). Neurosurgical treatment of malignant
obsessive-compulsive disorder. Psychiatr. Clin. North Am. 15,
921–938.
Mundt, A., Klein, J., Joel, D., Heinz, A., Djodari-Irani, A., Harnack, D., et al.
(2009). High-frequency stimulation of the nucleus accumbens core and shell
reduces quinpirole-induced compulsive checking in rats. Eur. J. Neurosci. 29,
2401–2412. doi: 10.1111/j.1460-9568.2009.06777.x
Ninan, P., Koran, L., Kiev, A., Davidson, J., Rasmussen, S., Zajecka, J., et al.
(2006). High-dose sertraline strategy for nonresponders to acute treatment
for obsessive-compulsive disorder: a multicenter double-blind trial. J. Clin.
Psychiatry 67, 15–22. doi: 10.4088/JCP.v67n0103
Olesenn, J., Gustavsson, A., Svensson, M., Wittchen, H.-U., Jönsson, B.,
CDBE2010 study group, et al. (2012). The economic cost of brain disorders
in Europe. Eur. J. Neurol. 19, 155–162. doi: 10.1111/j.1468-1331.2011.03590.x
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D.,
et al. (2002). Treatment non-response in OCD: methodological issues and
operational definitions. Int. J. Neuropsychopharmacol. 5, 181–191. doi: 10.
1017/s1461145702002900
Rolls, E. T. (2012). Glutamate, obsessive-compulsive disorder, schizophrenia and
the stability of cortical attractor neuronal networks. Pharmacol. Biochem.
Behav. 100, 736–751. doi: 10.1016/j.pbb.2011.06.017
Rosenblueth, A., and Wiener, N. (1945). The role of models in science. Philos. Sci.
12, 316–321.
Rotge, J. Y., Guehl, D., Dilharreguy, B., Cuny, E., Tignol, J., Bioulac, B., et al. (2008).
Provocation of obsessive-compulsive symptoms: a quantitative voxel-based
meta-analysis of functional neuroimaging studies. J. Psychiatry Neurosci. 33,
405–412.
Salín-Pascual, R. J., and Basañez-Villa, E. (2003). Changes in compulsion
and anxiety symptoms with nicotine transdermal patches in non-smoking
obsessive-compulsive disorder patients. Rev. Invest. Clin. 55, 650–654.
Saxena, S., Brody, A., Schwarz, M. J., and Baxter, L. R. (1998). Neuroimaging and
frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry
Suppl. S173, 26–37.
Schepisi, C., De Carolis, L., and Nencini, P. (2013). Effects of the 5HT2C antagonist
SB242084 on the pramipexole-induced potentiation of water contrafreeloading,
a putative animal model of compulsive behavior. Psychopharmacology (Berl)
227, 55–66. doi: 10.1007/s00213-012-2938-z
Schmidt, T. T., Rea, E., Shababi-Klein, J., Panagis, G., and Winter, C. (2013).
Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole
model of obsessive—compulsive disorder. Int. J. Neuropsychopharmacol. 16,
1083–1091. doi: 10.1017/s1461145712000983
Skoog, G., and Skoog, I. (1999). A 40-year follow-up of patients with
obsessive-compulsive disorder. Arch. Gen. Psychiatry 56, 121–127. doi: 10.
1001/archpsyc.56.2.121
Stein, D. J. (2002). Obsessive-compulsive disorder. Lancet 360, 397–405. doi: 10.
1016/S0140-6736(02)09620-4
Szechtman, H., Ahmari, S. E., Beninger, R. J., Eilam, D., Harvey, B. H., Edemann-
Callesen, H., et al. (2016). Obsessive-compulsive disorder: insights from animal
models. Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2016.04.019. [Epub
ahead of print]
Szechtman, H., Eckert, M. J., Tse, W. S., Boersma, J. T., Bonura, C. A.,
McClelland, J. Z., et al. (2001). Compulsive checking behavior of
quinpirole-sensitized rats as an animal model of Obsessive-Compulsive
Disorder (OCD): form and control. BMC Neurosci. 2:4. doi: 10.1186/1471-
2202-2-4
Szechtman, H., Sulis, W., and Eilam, D. (1998). Quinpirole induces compulsive
checking behavior in rats: a potential animal model of obsessive-compulsive
disorder (OCD). Behav. Neurosci. 112, 1475–1485. doi: 10.1037/0735-7044.112.
6.1475
Szechtman, H., Talangbayan, H., Canaran, G., Dai, H., and Eilam, D.
(1994). Dynamics of behavioral sensitization induced by the dopamine
agonist quinpirole and a proposed central energy control mechanism.
Psychopharmacology (Berl) 115, 95–104. doi: 10.1007/BF02244757
Szechtman, H., and Woody, E. (2004). Obsessive-compulsive disorder as a
disturbance of security motivation. Psychol. Rev. 111, 111–127. doi: 10.
1037/0033-295X.111.1.111
Tizabi, Y., Louis, V. A., Taylor, C. T., Waxman, D., Culver, K. E., and
Szechtman, H. (2002). Effect of nicotine on quinpirole-induced checking
behavior in rats: implications for obsessive-compulsive disorder. Biol.
Psychiatry 51, 164–171. doi: 10.1016/s0006-3223(01)01207-0
Ursu, S., and Carter, C. S. (2010). An initial investigation of the orbitofrontal cortex
hyperactivity in obsessive-compulsive disorder: exaggerated representations of
anticipated aversive events? Neuropsychologia 47, 2145–2148. doi: 10.1016/j.
neuropsychologia.2009.03.018
van Grootheest, D. S., Cath, D. C., Beekman, A. T., and Boomsma, D. I. (2005).
Twin studies on obsessive-compulsive disorder: a review. Twin Res. Human
Genet. 8, 450–458. doi: 10.1375/twin.8.5.450
Willner, P. (1986). Validation criteria for animal models of human
mental disorders: learned helplessness as a paradigm case. Prog.
Neuropsychopharmacol. Biol. Psychiatry 10, 677–690. doi: 10.1016/0278-
5846(86)90051-5
Winter, C., Mundt, A., Jalali, R., Joel, D., Harnack, D., Morgenstern, R.,
et al. (2008). High frequency stimulation and temporary inactivation of the
subthalamic nucleus reduce quinpirole-induced compulsive checking behavior
in rats. Exp. Neurol. 210, 217–228. doi: 10.1016/j.expneurol.2007.10.020
Yadin, E., Friedman, E., and Bridger, W. H. (1991). Spontaneous alternation
behavior: an animal model for obsessive-compulsive disorder? Pharmacol.
Biochem. Behav. 40, 311–315. doi: 10.1016/0091-3057(91)90559-k
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Stuchlik, Radostová, Hatalova, Vales, Nekovarova, Koprivova,
Svoboda and Horacek. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution and
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Behavioral Neuroscience | www.frontiersin.org 7 October 2016 | Volume 10 | Article 209
